122 related articles for article (PubMed ID: 37832794)
1. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
[TBL] [Abstract][Full Text] [Related]
2. Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1.
Weekes D; Kashima TG; Zandueta C; Perurena N; Thomas DP; Sunters A; Vuillier C; Bozec A; El-Emir E; Miletich I; Patiño-Garcia A; Lecanda F; Grigoriadis AE
Oncogene; 2016 Jun; 35(22):2852-61. PubMed ID: 26387545
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
Suh J; Kim DH; Lee YH; Jang JH; Surh YJ
Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854
[TBL] [Abstract][Full Text] [Related]
4. Apurinic/apyrimidinic endonuclease 1 induced upregulation of fibroblast growth factor 2 and its receptor 3 induces angiogenesis in human osteosarcoma cells.
Ren T; Qing Y; Dai N; Li M; Qian C; Yang Y; Cheng Y; Li Z; Zhang S; Zhong Z; Wang D
Cancer Sci; 2014 Feb; 105(2):186-94. PubMed ID: 24329908
[TBL] [Abstract][Full Text] [Related]
5. miRNA-646 suppresses osteosarcoma cell metastasis by downregulating fibroblast growth factor 2 (FGF2).
Sun XH; Geng XL; Zhang J; Zhang C
Tumour Biol; 2015 Mar; 36(3):2127-34. PubMed ID: 25403884
[TBL] [Abstract][Full Text] [Related]
6. Amphiregulin enhances intercellular adhesion molecule-1 expression and promotes tumor metastasis in human osteosarcoma.
Liu JF; Tsao YT; Hou CH
Oncotarget; 2015 Dec; 6(38):40880-95. PubMed ID: 26503469
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor alpha promotes osteosarcoma metastasis by ICAM-1 and PI3K/Akt signaling pathway.
Hou CH; Lin FL; Tong KB; Hou SM; Liu JF
Biochem Pharmacol; 2014 Jun; 89(4):453-63. PubMed ID: 24685520
[TBL] [Abstract][Full Text] [Related]
8. Activation of the FGF2/FGFR1 autocrine loop for cell proliferation and survival in uveal melanoma cells.
Lefèvre G; Babchia N; Calipel A; Mouriaux F; Faussat AM; Mrzyk S; Mascarelli F
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1047-57. PubMed ID: 19029025
[TBL] [Abstract][Full Text] [Related]
9. Low prognostic implication of fibroblast growth factor family activation in triple-negative breast cancer subsets.
Lee HJ; Seo AN; Park SY; Kim JY; Park JY; Yu JH; Ahn JH; Gong G
Ann Surg Oncol; 2014 May; 21(5):1561-8. PubMed ID: 24385208
[TBL] [Abstract][Full Text] [Related]
10. Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy.
Ling L; Tan SK; Goh TH; Cheung E; Nurcombe V; van Wijnen AJ; Cool SM
Mol Cancer; 2015 Jul; 14():136. PubMed ID: 26201468
[TBL] [Abstract][Full Text] [Related]
11. Long Noncoding MT1JP Enhanced the Inhibitory Effects of miR-646 on FGF2 in Osteosarcoma.
Yang L; Liu G; Xiao S; Wang L; Liu X; Tan Q; Li Z
Cancer Biother Radiopharm; 2020 Jun; 35(5):371-376. PubMed ID: 32196384
[No Abstract] [Full Text] [Related]
12. GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells toward Breast Tumor Progression.
Santolla MF; Vivacqua A; Lappano R; Rigiracciolo DC; Cirillo F; Galli GR; Talia M; Brunetti G; Miglietta AM; Belfiore A; Maggiolini M
Cells; 2019 Mar; 8(3):. PubMed ID: 30866584
[TBL] [Abstract][Full Text] [Related]
13. siRNA mediated knockdown of fibroblast growth factor receptors 1 or 3 inhibits FGF-induced anchorage-independent clonogenicity but does not affect MAPK activation.
Estes NR; Thottassery JV; Kern FG
Oncol Rep; 2006 Jun; 15(6):1407-16. PubMed ID: 16685373
[TBL] [Abstract][Full Text] [Related]
14. Different tyrosine autophosphorylation requirements in fibroblast growth factor receptor-1 mediate urokinase-type plasminogen activator induction and mitogenesis.
Dell'Era P; Mohammadi M; Presta M
Mol Biol Cell; 1999 Jan; 10(1):23-33. PubMed ID: 9880324
[TBL] [Abstract][Full Text] [Related]
15. Histone demethylase JMJD2B and JMJD2C induce fibroblast growth factor 2: mediated tumorigenesis of osteosarcoma.
Li X; Dong S
Med Oncol; 2015 Mar; 32(3):53. PubMed ID: 25636512
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of FGF Receptor-1 Suppresses Alcohol Consumption: Role of PI3 Kinase Signaling in Dorsomedial Striatum.
Even-Chen O; Barak S
J Neurosci; 2019 Oct; 39(40):7947-7957. PubMed ID: 31375540
[TBL] [Abstract][Full Text] [Related]
17. TET2-dependent IL-6 induction mediated by the tumor microenvironment promotes tumor metastasis in osteosarcoma.
Itoh H; Kadomatsu T; Tanoue H; Yugami M; Miyata K; Endo M; Morinaga J; Kobayashi E; Miyamoto T; Kurahashi R; Terada K; Mizuta H; Oike Y
Oncogene; 2018 May; 37(22):2903-2920. PubMed ID: 29515232
[TBL] [Abstract][Full Text] [Related]
18. Effect of fibroblast growth factor 2 on degenerative endplate chondrocyte: From anabolism to catabolism.
Song H; Du H; Li J; Wang M; Wang J; Ju X; Mu W
Exp Mol Pathol; 2021 Feb; 118():104590. PubMed ID: 33285208
[TBL] [Abstract][Full Text] [Related]
19. Novel mechanisms of fibroblast growth factor receptor 1 regulation by extracellular matrix protein anosmin-1.
Hu Y; Guimond SE; Travers P; Cadman S; Hohenester E; Turnbull JE; Kim SH; Bouloux PM
J Biol Chem; 2009 Oct; 284(43):29905-20. PubMed ID: 19696444
[TBL] [Abstract][Full Text] [Related]
20. S100A4 Is Involved in Stimulatory Effects Elicited by the FGF2/FGFR1 Signaling Pathway in Triple-Negative Breast Cancer (TNBC) Cells.
Santolla MF; Talia M; Maggiolini M
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]